3 Results for "

SCA 136

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SCA 136" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-111200
CAS No.: 887258-94-8
Purity:  99.47%
Synonyms: SCA-136
Target:  

5-HT Receptor

Vabicaserin hydrochloride (SCA-136) is a brain-penetrant, orally active, and selective 5-HT2C receptor agonist (Ki = 3 nM; EC50 = 8 nM). Vabicaserin hydrochloride specifically activates Gq-coupled 5-HT2C receptors to promote calcium mobilization, thereby selectively reducing dopamine release in the mesolimbic system without affecting the nigrostriatal pathway . Vabicaserin hydrochloride is an antagonist of 5-HT2A/5-HT2B receptors. Vabicaserin hydrochloride can be used for research on schizophrenia, obesity, chronic pain, and neurodegenerative diseases (such as Machado-Joseph disease) .
loading...
    loading...
Cat. No.: HY-111200R
CAS No.: 887258-94-8
Synonyms: SCA 136 (Standard)
Vabicaserin hydrochloride (SCA 136) Standard is the analytical standard of Vabicaserin hydrochloride (HY-111200). This product is intended for research and analytical applications. Vabicaserin hydrochloride (SCA-136) is a brain-penetrant, orally active, and selective 5-HT2C receptor agonist (Ki = 3 nM; EC50 = 8 nM). Vabicaserin hydrochloride specifically activates Gq-coupled 5-HT2C receptors to promote calcium mobilization, thereby selectively reducing dopamine release in the mesolimbic system without affecting the nigrostriatal pathway . Vabicaserin hydrochloride is an antagonist of 5-HT2A/5-HT2B receptors. Vabicaserin hydrochloride can be used for research on schizophrenia, obesity, chronic pain, and neurodegenerative diseases (such as Machado-Joseph disease) .
loading...
    loading...
Cat. No.: HY-111200A
CAS No.: 887258-95-9
Synonyms: SCA-136 free base
Target:  

5-HT Receptor

Vabicaserin (SCA-136 free base) is a brain-penetrant, orally active, and selective 5-HT2C receptor agonist (Ki = 3 nM; EC50 = 8 nM). Vabicaserin specifically activates Gq-coupled 5-HT2C receptors to promote calcium mobilization, thereby selectively reducing dopamine release in the mesolimbic system without affecting the nigrostriatal pathway . Vabicaserin is an antagonist of 5-HT2A/5-HT2B receptors. Vabicaserin can be used for research on schizophrenia, obesity, chronic pain, and neurodegenerative diseases (such as Machado-Joseph disease) .
loading...
    loading...